Wedbush upgraded shares of Bicara Therapeutics (NASDAQ:BCAX – Free Report) to a strong-buy rating in a research note released on Wednesday,Zacks.com reports. Other equities research analysts have also ...
Some results have been hidden because they may be inaccessible to you